secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acrivon Therapeutics, Inc. (ACRV)
CIK:        0001781174
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001193125-24-003885
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acrivon updates corporate presentation at JPM; confirms cash runway into H2 2025
--------------------------------------------------------------------------------

- Participates in 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024.
- Updated corporate presentation includes product candidate development progress.
- Confirms projected cash runway into the second half of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781174/000119312524003885/0001193125-24-003885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781174/000119312524003885/d103829d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer